Universe Pharmaceuticals INC(UPC)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2025-09-30.

Universe Pharmaceuticals INC (UPC) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. UPC is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 4 institutional filers currently hold this stock. Based on the latest XBRL financial filings (FY 2025), Universe Pharmaceuticals INC reports quarterly revenue of $17.9B, net income of $-3.7B, an operating margin of -16.3%. Top institutional holders of UPC by reported 13-F value include UBS Group AG, OSAIC, HRT FINANCIAL, based on the most recent SEC filings. UPC trades on the Nasdaq exchange and files with the SEC under CIK 1809616. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate UPC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Universe Pharmaceuticals INC directly from SEC EDGAR.